DPT

DPT (N,N-dipropyltryptamine) is covered in Australia as a tryptamine derivative in Schedule 9 of the Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026. Schedule 9 is the Poisons Standard classification for prohibited substances, and the derivative entry applies unless a substance is included in Schedule 4. The Standard is made under the Therapeutic Goods Act 1989 and is used by states and territories in their poisons-control laws governing possession, manufacture and supply.

Listed in Belgium's most restrictive controlled substance category, approximately equivalent to Schedule II under the United States system. Manufacturing, distribution, and possession are prohibited.

DPT (dipropyltryptamin) is listed in Liste B of Denmark's Bekendtgørelse om euforiserende stoffer, which entered into force on 29 March 2026. Substances in Liste B may be used only for medical and scientific purposes. Their import, export, sale, purchase, delivery, receipt, manufacture, processing, and possession are permitted only in accordance with the Order's controls.

Controlled under the New Psychoactive Substances Act as of July 18, 2019.¹⁶ Production and importation with intent to market, administration to others, and trading are criminally punishable.¹⁸ Possession is prohibited but not subject to criminal penalty.

DPT is listed in Table A of Law 3459/2006, FEK A 103/25 May 2006. Law 4139/2013 Article 1(2) retains the Law 3459 tables as the operative table framework subject to delegated amendments. Article 2(1) makes Table A production, possession, transport, storage, procurement, processing, circulation and intermediation an exclusive State/EOF right, with supply limited to approved laboratory or hospital programmes; Article 2(5) requires Ministry of Health authorization for import/export. Article 20's at-least-eight-year and up-to-EUR-300,000 penalty is the general unauthorized-trafficking route, not an automatic sentence for every possession case: Articles 21 and 29 provide narrower fact-specific routes, including up to five months for sole personal use and possible non-punishment for entirely occasional conduct. The current consolidated legal-publication page is dated 31 July 2026, and the latest 2026 schedule amendment adds four other Table A substances without listing DPT.

DPT is a Schedule 1 controlled drug because it is structurally derived from tryptamine by di-n-propyl substitution at the side-chain nitrogen, a class expressly included in the Schedule. Unauthorised possession is an offence, and the Regulations prohibit production, supply, importation and exportation except as authorised.

Controlled under the Pharmaceutical Affairs Law. Possession and sale are prohibited.

Classified as a Schedule I controlled substance under national drug legislation. Possession, distribution, and production are illegal.

The Misuse of Drugs Act 1975 lists dipropyltryptamine (DPT) in Schedule 1 as a Class A controlled drug. The Act treats Schedule 1 substances as Class A controlled drugs and regulates their possession, supply, manufacture, importation, and exportation.

DPT (N,N-dipropyltryptamine) is listed in Norway’s Narkotikalisten, which forms part of the Narcotics Regulation; the regulation has been in force since 14 February 2013. Possession or use of narcotics without lawful authority is prohibited, while manufacture, import, wholesale activity, retail sale, supply and dispatch are subject to the controls and permissions in the Medicines Act.

DPT (N,N-dipropylotryptamine) is listed as a new psychoactive substance in Annex 3 to the Minister of Health's regulation. It has been listed since 6 April 2021, when the amending regulation entered into force. Possession contrary to the Act on Counteracting Drug Addiction is punishable by a fine; possession of a considerable quantity may also result in restriction of liberty or imprisonment for up to three years.

DPT remains expressly listed in Table II-A in the latest official republication effective 2026-05-09. Under current Article 21(1), unauthorized cultivation, production, manufacture, extraction, preparation, offering, sale, distribution, purchase, transfer, provision, transport, import, export, transit or illicit detention of a Table I-III substance outside Article 40 carries 4-12 years' imprisonment; authorized activity is not categorically prohibited by that provision. Article 25 provides 1-5 years where the unlawfulness is considerably diminished for a Table I-III, V or VI substance. For own consumption, current Article 40(1) keeps cultivation criminalized (up to 3 months' imprisonment or up to 30 days' fine), while Article 40(2) makes acquisition and detention for own consumption a contraordenação. More than the average 10-day amount is an indication that the purpose may not be own consumption, not an automatic trafficking conviction; if exclusive own use is proved despite the excess, the authority must order archiving, non-indictment or acquittal, with referral to the dissuasion commission. Lei n.º 30/2000 Article 15 permits a coima or non-pecuniary sanction for non-dependent consumers and non-pecuniary sanctions for dependent consumers; Article 17 lists alternatives including admonition and periodic presentation. The current Table II-A scope expressly includes possible salts and chemically designated isomers unless excluded. The current consolidated Decreto-Lei text contains no generic chemical-analogue clause; DPT's exact listing does not extend to every chemically similar tryptamine or other analogue.

Singapore's Misuse of Drugs Act 1973 lists N,N-Dipropyltryptamine (DPT) as a Class A drug in the First Schedule. The Act defines a substance specified in the First Schedule as a controlled drug and regulates its possession, consumption, trafficking, import, export and manufacture.

Classified as a narcotic substance on January 26, 2016 following its sale as a designer drug.⁵⁵ Manufacturing, trade, and possession are prohibited.

DPT is covered as a derivative of the tryptamine group in List No. 2 of Table I of Ukraine’s controlled-substances schedule. List No. 2 classifies especially dangerous psychotropic substances whose circulation is prohibited; its derivative clause excludes medicinal products, including active pharmaceutical ingredients, containing tryptamine derivatives. The schedule was approved by Cabinet of Ministers Resolution No. 770 of 6 May 2000.

Controlled under the Misuse of Drugs Act 1971 through the tryptamine catch-all clause, which covers compounds structurally derived from tryptamine by substitution at the nitrogen atom of the sidechain with alkyl substituents.⁶¹ Class A classification carries the most severe penalties for possession, production, and distribution.

DPT (N,N-dipropyltryptamine) is listed in the annex to Finland's Government Decree on psychoactive substances prohibited from the consumer market. Section 1 of the decree makes the substances named in that annex prohibited psychoactive substances for the consumer market.

The current BetmVV-EDI expressly identifies item 253 in Annex 6 (Verzeichnis e) as DPT / N,N-Dipropyltryptamin. BetmKV Art. 3(2)(e) subjects Verzeichnis e materials and products to the control measures applicable to Verzeichnis-a narcotics, and Art. 5(2) assigns operating permits for Verzeichnis-e substances to the EDI. The industrial-use and private-use sentence is attached to item 250 (1,4-Butandiol), not item 253.

DPT remains unscheduled at the federal level, meaning possession, purchase, and distribution are generally legal under federal law. However, several states have independently scheduled the substance: Florida classifies it as Schedule I, Maine lists it as Schedule X, and Oklahoma has placed it in Schedule I. The Federal Analogue Act may apply if sold for human consumption.